Investigational Site Number 840-080 — Morehead City, North Carolina

Investigational Site Number 840-080 is a clinical research site located in Morehead City, North Carolina, United States 28557.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site Number 840-080 has participated in 1 clinical trials.

Therapeutic areas: Type 1 Diabetes Mellitus.

Sponsors: Sanofi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Morehead City

Browse all research sites in North Carolina · View every site in Morehead City

• The Coleman Radiation Center-Carteret General Hospital
• Coleman Radiation Oncology Center at Carter General Hospital
• Carteret General Hospital
• Carteret County General Hospital
• Lucas Research
• Carteret Medical Group
• Research Site
• West Clinical Research
• Novo Nordisk Investigational Site
• Diabetes & Endocrinology Consultants PC
• GSK Investigational Site
• Diabetes and Endocrinology Consultants, P.C

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840-080?

Investigational Site Number 840-080 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840-080 conducted?

Investigational Site Number 840-080 has 1 clinical trials on record. Their work covers Type 1 Diabetes Mellitus.

Is Investigational Site Number 840-080 accredited by Crixeo Clinical Trials?

Investigational Site Number 840-080 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840-080?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.